Karus Therapeutics presenting at Biotech Showcase 2015

Dr Simon Kerry, CEO of Karus Therapeutics, a leader in the development of innovative medicines for the treatment of inflammatory disease and cancer, will be attending and presenting at Biotech Showcase 2015, 12-14 January 2015 in San Francisco. Simon will be presenting on Tuesday 13th January 2015 at 10:45am in the Mission I room. For more […]

Design and Development of Novel, Highly-Selective HDAC6 Inhibitors for the Treatment of Cancer

Design and Development of Novel, Highly-Selective HDAC6 Inhibitors for the Treatment of Cancer. Cecil A., Rogers H., Bone E., Colman L., Finan P., Haque K., Lensun L., Roitt R., Silva F., Ward P., Whale A., Shuttleworth S. NCRI Meeting, Liverpool, UK, November 3, 2014, A114.

Design and Development of a Novel Series of Orally-Active, Selective PI3K-p110ß/δ Inhibitors for the Treatment of Cancer (NCRI Meeting)

Design and Development of a Novel Series of Orally-Active, Selective PI3K-p110ß/d Inhibitors for the Treatment of Cancer. Cecil A., Rogers H., Bone E., Colman L., Finan P., Haque K., Lensun L., Roitt S., Silva F., Ward P., Whale A. Shuttleworth S. NCRI Meeting, Liverpool, UK, November 3, 2014, A143.

Karus Therapeutics Appoints New Head of Clinical Development and Head of Biology

Oxford, UK, 21 October 2014 – Karus Therapeutics, a leader in the development of innovative medicines for the treatment of inflammatory diseases and cancer, today announced that it has further strengthened its R&D team with two new appointments; Dr Simon Roitt, who joins as Head of Clinical Development and Dr Peter Finan, who has been […]

Karus Therapeutics presenting at NCRI Cancer Conference

Stephen Shuttleworth, CSO of Karus Therapeutics, a leader in the development of innovative medicines for the treatment of inflammatory disease and cancer, will be attending and presenting two posters at the 10th NCRI Cancer Conference, 2-5 November 2014 in Liverpool. For more information on Karus’s presentations or for media enquiries, please contact karus@instinctif.com.

Karus Therapeutics presenting at SACHS Biotech in Europe Forum

Karus Therapeutics, a leader in the development of innovative medicines for the treatment of inflammatory disease and cancer, has announced that Simon Kerry, CEO, will be presenting at the SACHS Biotech in Europe Forum, 30 September – 01 October, 2014 in Basel, Switzerland. The company presentation will take place at 15:45 CET on 30th September […]

Karus Therapeutics features in SciBX

Oxford, UK, 15 May 2014 – Karus Therapeutics, a leader in the development of innovative medicines for the treatment of inflammatory disease and cancer, was featured in the cover story of SciBX, ‘Chromatin’s rising tide’.  The article, which covers the discussions of a panel of thought leaders at the SciBX Summit on Innovation in Drug […]

Design and Development of a Novel Series of Orally-Active, Selective PI3K-p110ß/δ Inhibitors for the Treatment of Cancer (San Diego)

Design and Development of a Novel Series of Orally-Active, Selective PI3K-p110ß/δ Inhibitors for the Treatment of Cancer. Shuttleworth S.J., Bone E.A., Cecil A.R.L., Colman L., Fulton R., Haque K., Hill T.J., McGovern Y., Nodes W.J., Rogers H., Silva F.A., Whale A.D. Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr […]

Design and Development of a Novel Series of HDAC6-Selective Inhibitors for the Treatment of Cancer

Design and Development of a Novel Series of HDAC6-Selective Inhibitors for the Treatment of Cancer. Shuttleworth S.J., Bone E.A; Cecil A.R.L., Colman L., Fulton R., Hill T.J., McCormick S., Nodes W.J., Rogers H., Silva F.A., Tomassi C.D., Whale A.D. Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; […]

Karus Therapeutics presenting at AACR Annual Meeting 2014

Oxford, UK, 3 April 2014 – Karus Therapeutics, a leader in the development of innovative medicines for the treatment of inflammatory disease and cancer, has announced that it will be giving two poster presentations at the AACR Annual Meeting in San Diego, 5-9th April 2014. Stephen Shuttleworth, Karus’s CSO, will present two posters describing the […]